Two biotechs raise a combined $556M in latest spurt of IPOs
Summary
Seaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that ...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.